ELI LILLY & Co — Director's Dealing 2024

Jul 19, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-07-15

Reporting Person: Brooks Gordon J. (Interim CFO, Group VP)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12403	Direct
Common Stock	3694	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit	$	2024-11-01	Common Stock (3067)		Direct
Restricted Stock Unit	$	2026-02-16	Common Stock (276)		Direct
Restricted Stock Unit	$	2026-11-01	Common Stock (4600)		Direct
Restricted Stock Unit	$	2027-02-16	Common Stock (278)		Direct
Phantom Stock	$		Common Stock (741)		Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: Represent benefits under Eli Lilly and Company's excess savings plan distributable in cash upon the reporting person's retirement or other termination of service.